000			02380 a2200709 4500
005			20250515224154.0
264		0	_c20101004
008			201010s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2010.04.020 _2doi
040			_aNLM _beng _cNLM
100	1		_aTian, Hong-Lei
245	0	0	_aA novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway. _h[electronic resource]
260			_bCancer letters _cNov 2010
300			_a18-30 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAbietanes
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents, Phytogenic _xchemical synthesis
650	0	4	_aAntioxidants _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCytochromes c _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDoxorubicin _xpharmacology
650	0	4	_aFemale
650	0	4	_aHL-60 Cells
650	0	4	_aHeLa Cells
650	0	4	_aHep G2 Cells
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xpharmacology
650	0	4	_aPhenanthrenes _xchemical synthesis
650	0	4	_aPropyl Gallate _xpharmacology
650	0	4	_aProtein Transport
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aSolubility
650	0	4	_aTime Factors
650	0	4	_aTransfection
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_abcl-2-Associated X Protein _xmetabolism
700	1		_aYu, Ting
700	1		_aXu, Nai-Ning
700	1		_aFeng, Chao
700	1		_aZhou, Li-Ying
700	1		_aLuo, Hou-Wei
700	1		_aChang, Donald C
700	1		_aLe, Xiao-Feng
700	1		_aLuo, Kathy Qian
773	0		_tCancer letters _gvol. 297 _gno. 1 _gp. 18-30
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2010.04.020 _zAvailable from publisher's website
999			_c19847581 _d19847581